In-vivo Imaging Market Size

In-vivo Imaging Market size is poised to reach USD 6 Billion by the end of 2036, growing at a rate of 6% during the forecast period, i.e., 2024 – 2036. In the year 2023, the industry size of in-vivo imaging was USD 3 Billion. The reason behind the growth is impelled by the increasing cases of cancer across the globe. Cancer is the primary cause of death, and in nations with low Human Development Indexes (HDI), the number of new cases is rising rapidly.

In the study of cancer biology as well as in clinical prognosis and treatment, In-vivo imaging has emerged as a crucial tool as it offers one-of-a-kind, cutting-edge capabilities to help with the development of protocols for cancer detection and diagnosis.

According to estimates, by 2040, there will be more than 26 million new instances of cancer annually throughout the world.

The rising trend of precision medicine is believed to fuel the market growth. Precision medicine has helped reduce superfluous, pointless testing and unnecessary hospital admissions and has led to more accurate diagnoses and forecasts of disease risk before any symptoms appear. 

Moreover, precision medicine is an effective method for examining the human body in vivo molecular imaging, which allows for more accurate diagnostics and real-time monitoring.